Pursuing new targets and indications for deep brain stimulation: Considerations for device-related clinical research in the United States

Neuromodulation

Volumn 14, Issue 4, 2011, Pages 389-392

  Tomycz, Nestor D ^a   Cheng, Boyle C ^a   Cantella, Diane ^a   Angle, Cynthia ^a   Oh, Michael Y ^a   Whiting, Donald M ^a  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DEPTH STIMULATION; CLINICAL RESEARCH; COST EFFECTIVENESS ANALYSIS; DEVICE APPROVAL; DEVICE SAFETY; DYSTONIA; FOOD AND DRUG ADMINISTRATION; HUMAN; LETTER; MEDICAL INSTRUMENTATION; OBESITY; RISK FACTOR; TREATMENT INDICATION; UNITED STATES;

BIOMEDICAL RESEARCH; DEEP BRAIN STIMULATION; DEVICE APPROVAL; EQUIPMENT DESIGN; ETHICS COMMITTEES, RESEARCH; HUMANS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 80051484403     PISSN: 10947159     EISSN: 15251403     Source Type: Journal    
DOI: 10.1111/j.1525-1403.2011.00377.x     Document Type: Letter

References (16)

1. Medical device regulations: global overview and guiding principles. World Health Organization 2003.
2. Section 201(h) of the Federal Food Drug & Cosmetic (FD&C) Act.
3. Pena C, Bowsher K, Costello A, De Luca R, Doll S, Li K, et al,. An overview of FDA medical device regulation as it relates to deep brain stimulation devices. IEEE 2007; 15: 421-424. (Pubitemid 47460419)
4. U.S. Department of Health and Human Services. U.S. Food and Drug Administration. Medical Devices.
5. Fontanarosa PB, Flanagin A, DeAngelis CD,. Reporting conflicts of interest, financial aspects of research, and role of sponsors in funded studies. JAMA 2005; 294: 110-111. (Pubitemid 41002847)
6. Dicker HB, Fang D, Heinig SJ, Johnson E, Korn D,. New physician-investigators receiving national institutes of health research project grants: a historical perspective on the "endangered species." JAMA 2007; 297: 2496-2501. (Pubitemid 46953403)
7. Mann M, Tendulkar A, Birger N, Howard C, Ratcliffe MB,. National institutes of health funding for surgical research. Ann Surg 2008; 247: 217-221. (Pubitemid 351156762)
8. IDE Refuse to Accept Procedures
9. Arbit HM, Paller MS,. A program to provide regulatory support for investigator-initiated clinical research. Acad Med 2006; 81: 146-153. (Pubitemid 44356692)
10. Bernad DM,. Humanitarian use device and humanitarian device exemption regulatory programs: pros and cons. Expert Rev Med Devices 2009; 6: 13-145.
11. U.S. Department of Health and Human Services. U.S. Food and Drug Administration. Medical Devices.
12. IRB Membership. Code of Federal Regulations (21 CFR 56.107).
13. Guidance for IRBs, clinical investigators, and sponsors. IRB continuing review after clinical investigation approval.
14. Montgomery EB,. Deep brain stimulation for hyperkinetic disorders. Neurosurg Focus 17: E1-E8, 2004.
15. Maisel WH,. Medical device regulation: an introduction for the practicing physician. Ann Intern Med 2004; 140: 296-302. (Pubitemid 38200536)
16. Nelson DB, Block KP, Bosco JJ, Burdick JS, Curtis WD, Faigel DO, et al,. Medical device evaluation by the Food and Drug Administration (FDA). Gastrointest Endosc 2001; 53: 880-884.